MDxHealth SA (MDXH)
NASDAQ: MDXH · Delayed Price · USD
9.08
-0.15 (-1.63%)
At close: Nov 30, 2021 4:00 PM
9.02
-0.06 (-0.66%)
After-hours:Nov 30, 2021 4:00 PM EST
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
| Year | 2020 | 2019 |
|---|---|---|
| Revenue | 18.46 | 11.79 |
| Revenue Growth | 56.64% | - |
| Cost of Revenue | 10.42 | 11.76 |
| Gross Profit | 8.04 | 0.03 |
| Selling, General & Admin | 30.74 | 33.01 |
| Research & Development | 4.54 | 9 |
| Other Operating Expenses | -0.12 | 1.2 |
| Operating Expenses | 35.17 | 43.2 |
| Operating Income | -27.12 | -43.17 |
| Interest Expense / Income | 1.54 | 0.52 |
| Other Expense / Income | -0 | -0.01 |
| Pretax Income | -28.66 | -43.68 |
| Income Tax | 0 | -0.58 |
| Net Income | -28.66 | -43.1 |
| Net Income Common | -28.66 | -43.1 |
| Shares Outstanding (Basic) | 156 | - |
| EPS (Basic) | -3.40 | -6.90 |
| EPS (Diluted) | -3.40 | -6.90 |
| Free Cash Flow Per Share | -1.33 | - |
| Gross Margin | 43.58% | 0.25% |
| Operating Margin | -146.93% | -366.30% |
| Profit Margin | -155.27% | -365.72% |
| Free Cash Flow Margin | -112.57% | -189.75% |
| Effective Tax Rate | 0.00% | 1.32% |
| EBITDA | -23.79 | -39.74 |
| EBITDA Margin | -128.86% | -337.20% |
| EBIT | -27.12 | -43.16 |
| EBIT Margin | -146.91% | -366.22% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).